Actos Buyers Fight Takeda Appeal Bid In Drug Delay Case

By Christopher Cole (December 16, 2019, 6:03 PM EST) -- End payors and direct buyers of the diabetes drug Actos have urged a New York federal judge to nix Takeda's bid to immediately appeal her decision preserving some class action claims against the drugmaker, which they have accused of using patent suits to hold off generic competitors....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!